oru.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Contemporary treatment of renal tumors: a questionnaire survey in the Nordic countries (the NORENCA-I study)
Department of Urology, Helsinki University Hospital, Helsinki, Finland.
Department of Urology, Helsinki University Hospital, Helsinki, Finland.
Department of Urology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Department of Urology, Landspitali University Hospital, Reykjavik, Iceland.
Show others and affiliations
2017 (English)In: Scandinavian journal of urology, ISSN 2168-1805, E-ISSN 2168-1813, Vol. 51, no 5, p. 360-366Article in journal (Refereed) Published
Abstract [en]

OBJECTIVE: The five Nordic countries comprise 25 million people, and have similar treatment traditions and healthcare systems. To take advantage of these similarities, a collaborative group (Nordic Renal Cancer Group, NORENCA) was founded in 2015.

MATERIALS AND METHODS: A questionnaire of 17 questions on renal tumor management and surgical education was designed and sent to 91 institutions performing renal tumor surgery in 2015. The response rate was 68% (62 hospitals), including 28 academic, 25 central and nine district hospitals. Hospital volume was defined as low (LVH: < 20 operations), intermediate (IVH: 20-49 operations), high (HVH: 50-99) and very high (VHVH: ≥ 100). Descriptive statistics were performed.

RESULTS: Fifteen centers were LVH, 16 IVH, 21 HVH and 10 VHVH. Of all 3828 kidney tumor treatments, 55% were radical nephrectomies (RNs), 37% partial nephrectomies (PNs) and 8% thermoablations. For RN and PN, the percentages of open, laparoscopic and robotic approaches were 47%, 40%, 13% and 47%, 20%, 33%, respectively. The mean complication rate (Clavien-Dindo 3-5) was 4.9%, and 30 day mortality (TDM) was 0.5%. The median length of hospital stay was 4 days. Training with a simulator, black box or animal laboratory was possible in 48%, 74% and 21% of institutions, respectively.

CONCLUSIONS: Despite some differences between countries, the data suggest an overall general common Nordic treatment attitude for renal tumors. Furthermore, the data demonstrate high adherence to international standards, with a high proportion of PN and acceptable rates for major complications and TDM.

Place, publisher, year, edition, pages
Taylor & Francis, 2017. Vol. 51, no 5, p. 360-366
Keywords [en]
Complication, kidney cancer, minimally invasive methods, mortality, nephrectomy, surgery
National Category
Surgery Urology and Nephrology
Identifiers
URN: urn:nbn:se:oru:diva-60813DOI: 10.1080/21681805.2017.1326524ISI: 000415626400004PubMedID: 28644697Scopus ID: 2-s2.0-85021235562OAI: oai:DiVA.org:oru-60813DiVA, id: diva2:1148292
Note

Funding Agency:

Scandinavian Association of Urology (NUF)

Available from: 2017-10-10 Created: 2017-10-10 Last updated: 2018-08-30Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records BETA

Sundqvist, Pernilla

Search in DiVA

By author/editor
Sundqvist, Pernilla
By organisation
School of Medical Sciences
In the same journal
Scandinavian journal of urology
SurgeryUrology and Nephrology

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 82 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf